Drug Trial Radar · NCT03742908
Application of Intra-operative Prophylactic Antibiotics/Antiseptics in Chinese Breast Reconstruction Patients
Last checked: Nov 20, 2026Latest source record: Nov 15, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
291
Planned (sponsor's estimate)
Start
Jun 16, 2018
Primary completion
Oct 31, 2021
Study completion Oct 31, 2021
Sponsor
- Lead sponsor
- Tianjin Medical University Cancer Institute and HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Nov 15, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- Female only
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study aims to investigate different approaches of local application of antibiotics/antiseptics intraoperatively in Chinese patients undergoing post-mastectomy implant based breast reconstruction, and aims to single out an intervention method that limits the use of antibiotics and maintains low rates of surgical site infection and capsular contracture. Patients who undergo post mastectomy breast reconstruction in the breast reconstruction department in Tianjin Medical University Cancer Institute and Hospital are eligible to enter the study.
Conditions
- Breast Neoplasms
Interventions
Cefazolin/clindamycinDrug
Local implant immersion and/or breast pocket irrigation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurrence of minor surgical site infectionTime frame: assessed up to 3 months post-op
- Occurrence of major surgical site infectionTime frame: assessed up to 3 months post-op
- Occurrence of capsular contractureTime frame: assessed from 3 months post-op up to 2 years post-op or until the trial ends, whichever comes first
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.